Effect of age on cytokine production in humans

Journal of the American Aging Association

Volumn 21, Issue 4, 1998, Pages 137-151

  Bernstein, Erica D ^a   Murasko, Donna M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; AGING; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GENETIC HETEROGENEITY; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN TISSUE; POPULATION RISK; REVIEW;

EID: 0032462502     PISSN: 01619152     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11357-998-0024-6     Document Type: Article

References (62)

1. Shearer GM: Th1/Th2 changes in aging. Mech. Ageing Develop., 94:1-5, 1997.
2. Hobbs MV, Weigle WO, Noonan DJ, Torbett BE, McEvilly RJ, Koch RJ, et al: Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J. Immunol., 150:3602-3614, 1993.
3. Albright JW, Zuiga-Pflcker JC, Albright JF: Transcriptional control of IL-2 and IL-4 in T cells of young and old mice. Cell. Immunol., 164:170-175, 1995.
4. + cells and cell subsets from young and old mice. Cell. Immunol., 154:264-272, 1994.
5. Adibzadeh M, Pohla H, Rehbein A, Pawelec G: Long-term culture of monoclonal human T lymphocytes: models for immunosenescence? Mech. Ageing Develop., 83:171-183, 1995.
6. Ligthart GJ, Coberand JX, Geertzen HGM, Meinders AE, Knook DL, Hijmins W: Necessity of the assessment of health status in human immunogerontological studies: Evaluation of the SENIEUR protocol. Mech. Ageing Develop., 55:89-105, 1990.
7. Meydani S: Vitamin/mineral supplementation, the aging immune response, and risk of infection. Nutr. Rev., 51:106-109, 1993.
8. Venkatraman JT, Fernandes G: Exercise, immunity and aging. Aging Clin. Exp. Res., 9:42-56, 1997.
9. Barcellini W, Borghi MO, Sguotti C, Palmieri R, Frasca D, Meroni PL et al: Heterogeneity of immune responsiveness in healthy elderly subjects. Clin. Immunol. Immunopath., 47:142-151, 1988.
10. Murasko DM, Nelson BJ, Matour D, Goonewardene IM, Kaye D: Heterogeneity of changes in lymphoproliferative ability with increasing age. Exper. Gerontol., 26:269-279, 1991.
11. Lombard PR, Steiner G: Preliminary report on cytokine determination in human synovial fluids: a consensus study of the European Workshop for Rheumatology Research. Clin. Exp. Rheumat., 10:515-520, 1992.
12. Holbrook NJ, Chopra RK, McCoy MT, Nagel JE, Powers DC, Adler WH et al.: Expression of interleukin-2 and the interleukin-2 receptor in aging rats. Cell. Immunol., 120:1-9, 1989
13. Kuby J: Immunology. New York: W.H. Freeman and Company; 1994.
14. Gillis S, Kozak R, Durante M, Weksler ME: Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J. Clin. Investig., 67:937-942, 1981.
15. Song LJ, Nagel JE, Chrest FJ, Collins GD, Adler WH: Comparison of CD3 and CD2 activation pathways in T cells from young and elderly adults. Aging, 4:307-315, 1992.
16. Schwab R, Pfeffer LM, Szabo P, Gamble D, Schnurr CM, Weksler ME: Defective expression of high affinity IL-2 receptors on activated T cells from aged humans. Intern. Immunol., 2:239-246, 1990.
17. Chopra RK, Holbrook NJ, Powers DC, McCoy MT, Adler WH, Nagel J:. Interleukin 2, interleukin 2 receptor, and interferon-γ synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Clin. Immunol. Immunopath., 53:297-308, 1989.
18. Born J, Uthgenannt D, Dodt C, Nunninghoff D, Ringvolt E, WagnerT et al: Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. Mech. Ageing Develop., 84:113-126, 1995.
19. Song L, Kim YH, Chopra RK, Proust JJ, Nagel JE, Nordin AA et al: Age-related effects in T cell activation and proliferation. Exper. Gerontol., 28:313-321, 1993.
20. Xu X, Beckman I, Bradley J: Age-related changes in the expression of IL-2 and high-affinity IL-2-binding sites. Intern. Arch. Allergy & Immunol., 102:224-231, 1993.
21. Orson FM, Saadeh CK, Lewis DE, Nelson DL: Interleukin 2 receptor expression by T cells in human aging. Cell, Immunol., 124:278-291, 1989.
22. Nagel JE, Chopra RK, Chrest FJ, McCoy MT, Schneider EL, Holbrook NJ et al.: Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J. Clin. Investig., 81:1096-1102, 1988.
23. + T cell differentiation in vivo. Clin. & Exper. Immunol., 96:528-534, 1994.
24. McElhaney JE, Beattie BL, Devine R, Grynoch R, Toth EL, Bleackley RC: Age-related decline in interleukin 2 production in response to influenza vaccine. J. Amer. Ger. Soc., 38:652-658, 1990.
25. McElhaney JE, Meneilly GS, Beattie BL, Helgason CD, Lee SF, Devine RD et al.: The effect of influenza vaccination on IL2 production in healthy elderly: implications for current vaccination practices. J. Gerontol., 47:M3-M8, 1992.
26. McElhaney JE, Meneilly GS, Pinkoski MJ, Lechelt KE, Bleackley RC: Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adults. Vaccine. 13:6-10, 1995.
27. Molteni M, Della Bella S, Mascagni B, Coppola C, De Micheli V, Zulian C et al. Secretion of cytokines upon allogeneic stimulation: effect of aging. J. Biol. Regul. Homeostatic Agents, 8:41-47, 1994.
28. Murasko DM, Goonewardene IM: T-cell function in aging; mechanisms of decline. Ann. Rev. Gerontol. Geriat., 10:71-96, 1990.
29. Walker C., Gauchat JF, DeWeck AL, Stadler BM: Analysis of leukocyte markers in elderly individuals. Aging Immunol. Infect. Dis. 2:31-43,1990.
30. Rabinowich H, Goses Y, Reshef T, Klajman A: Interieukin-2 production and activity in aged humans. Mech. Ageing Develop., 32:213-226, 1985.
31. Hessen MT, Kaye D, Murasko DM: Heterogeneous effects of exogenous lymphokines on lymphoproliferation of elderly subjects. Mech.Aging Develop.58:61-73, 1991.
32. Fulop Jr. T, Utsuyama M, Hirokawa K: Determination of interleukin 2 receptor number of Con A stimulated human lymphocytes with aging. J. Clin. & Laborat. Immunol., 34:31-36, 1991.
33. Negoro, S, Hara, H, Miyata, S, Saiki, O, Tanaka ,T, Yoshizaki, K et al: Mechanisms of age-related decline in antigen-specific T cell proliferative response: IL-2 receptor expression and recombinant IL-2 induced proliferative response of purified TAC-positive T cells. Mech. Ageing Develop., 36:223-241, 1986.
34. Matour D, Melnicoff M, Kaye D, Murasko DM: The role of T cell phenotypes in decreased lymphoproliferation of the elderly. Clin. Immunol. Immunopath., 50:82-99, 1988.
35. Candore G, DiLorenzo G, Melluso M, Cigna D, Colucci AT, Modica MA et al.: γ-interferon, interleukin-4 and interleukin-6 in vitro production in old subjects. Autoimmunity, 16:275-280, 1993.
36. 2 T cell subpopulations in the elderly. Mech. Ageing Develop., 87:197-209, 1996.
37. Al-Rayes H, Pachas W, Mirza N, Ahern DJ, Geha RS, Vercelli D: IgE regulation and lymphokine patterns in aging humans. J. Allerg. Clin. Immunol., 90:630-636, 1992.
38. Sindermann J, Kruse A, Frercks H-J, Schultz RM, Kirchner H: Investigations of the lymphokine system in elderly individuals. Mech. Ageing Develop., 70:149-159, 1993.
39. Weifeng C, Schulin L. Xinomei G, Xuewen F: The capacity of lymphocyte production by peripheral blood lymphocytes from aged humans. Immunolog. Invest., 15:575-583, 1986.
40. Bodnar Z, Steger MM, Saurwein-Teissl M, Maczek C, Grubeck-Loebenstein, B: Cytokine production in response to stimulation with tetanus toxoid, mycobacterium tuberculosis and influenza antigens in peripheral blood mononuclear cells and T cell lines from healthy elderlies. Intern. Arch. Allergy &Immunol., 112:323-330, 1997.
41. Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko DM: Cytokine production after influenza vaccination in a healthy elderly population. Vaccine, 16:1722-1731, 1998.
42. Salkind AR: Influence of age on the production of Fos and Jun by influenza virus-exposed T cells. J. Leuk. Biol., 56:817-820, 1994.
43. Castle S, Uyemura K, Wong W, Modlin R, Effros R: Evidence of enhanced type 2 immune response and impaired upregulation of a type 1 response in frail elderly nursing home residents. Mech. Ageing Develop., 94:7-16, 1997.
44. Kubo M, Cinader B: Polymorphism of age-related changes in interleukin (IL) production: differential changes of T helper subpopulations, synthesizing IL2, IL3 and IL4. Eur. J. Immunol., 20:1289-1296, 1990.
45. Miller RA. The aging immune system: primer and prospectus. Science, 273:70-74, 1996.
46. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E et al.: Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol., 23:2375-2378, 1993.
47. Ershler WB. Interleukin-6: A cytokine for gerontologists. J. Amer. Ger. Soc., 41:176-181, 1993.
48. Wei J, Xu H, Davies JL, Hemmings GP: Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci., 51:1953-1956, 1992.
49. Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB: Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J. Amer. Ger. Soc., 43:236-239, 1995.
50. Ershler WB, Sun WH, Binkley N, Gravenstein S, Volk MJ, Kamoske G et al.: Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymph. Cytokine Res.. 12:225-230, 1993.
51. James K, Premchand N, Skibinska A, Skibinski G, Nicol M, Mason JI: IL-6, DHEA and the ageing process. Mech. Ageing Develop., 93:15-24, 1997.
52. Peterson PK, Chao CC, Carson P, Hu S, Nichol K, Janoff EN: Levels of tumor necrosis factor α, interleukin 6, interleukin 10, and transforming growth factor β are normal in the serum of the healthy elderly. Clin. Infect. Dis., 19:1158-1159, 1994.
53. + large granular cell subpopulation. Scand. J. Immunol., 45:401-407, 1997.
54. Wu D, Meydani SN, Sastre J, Hayek M, Meydani M: In vitro glutathione supplementation enhances interleukin-2 production and mitogenic response of peripheral blood mononuclear cells from young and old subjects. J. Nutr., 124:655-663, 1994.
55. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K, Horie T. Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin. Exper. Immunol., 106:120-126, 1996.
56. McLachlan JA, Serkin CD, Morrey KM, Bakouche O: Antitumoral properties of aged human monocytes. J. Immunol., 154:832-843, 1995.
57. Clark JA, Peterson TC: Cytokine production and aging: overproduction of IL-8 in elderly males in response to lipopolysaccharide. Mech. Ageing Develop., 77:127-139, 1994.
58. Antonaci S, Tortorella C, Polignano A, Ottolenghi A, Jirillo E, Bonomo L: Modulating effects on CD25 and CD71 antigen expression by lectin-stimulated T lymphoctyes in the elderly. Immunopharm. Immunotox., 13:87-100, 1991.
59. Nagel JE, Chopra RK, Powers DC, Adler W.H.: Effect of age on the human high affinity interleukin 2 receptor of phytohaemagglutinin stimulated peripheral blood lymphocytes. Clin. & Exper. Immunol., 75:286-291, 1989.
60. Hara H, Tanaka T, Negoro S, Deguchi Y, Nishio S, Saiki O et al: Age-related changes of expression of IL-2 receptor subunits and kinetics of IL-2 internalization in T cells after mitogenic Stimulation. Mech. Ageing Develop., 45:167-175, 1988.
61. Provinciali M, DiStefano G, Fabris N: Evaluation of lymphokine-activated killer cell development in young and old healthy humans. Nat. Immun., 14:134-144, 1995.
62. Rea LM, Stewart M, Campbell P, Alexander HD, Crockard AD, Morris TC: Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology, 42:69-78, 1996.